Progression of coronary artery calcification seems to be inevitable, but predictable - results of the Heinz Nixdorf Recall (HNR) study

Aim Coronary artery calcification (CAC), as a sign of atherosclerosis, can be detected and progression quantified using computed tomography (CT). We develop a tool for predicting CAC progression. Methods and results In 3481 participants (45–74 years, 53.1% women) CAC percentiles at baseline (CACb) and after five years (CAC5y) were evaluated, demonstrating progression along gender-specific percentiles, which showed exponentially shaped age-dependence. Using quantile regression on the log-scale (log(CACb+1)) we developed a tool to individually predict CAC5y, and compared to observed CAC5y. The difference between observed and predicted CAC5y (log-scale, mean±SD) was 0.08±1.11 and 0.06±1.29 in men and women. Agreement reached a kappa-value of 0.746 (95% confidence interval: 0.732–0.760) and concordance correlation (log-scale) of 0.886 (0.879–0.893). Explained variance of observed by predicted log(CAC5y+1) was 80.1% and 72.0% in men and women, and 81.0 and 73.6% including baseline risk factors. Evaluating the tool in 1940 individuals with CACb>0 and CACb<400 at baseline, of whom 242 (12.5%) developed CAC5y>400, yielded a sensitivity of 59.5%, specificity 96.1%, (+) and (−) predictive values of 68.3% and 94.3%. A pre-defined acceptance range around predicted CAC5y contained 68.1% of observed CAC5y; only 20% were expected by chance. Age, blood pressure, lipid-lowering medication, diabetes, and smoking contributed to progression above the acceptance range in men and, excepting age, in women. Conclusion CAC nearly inevitably progresses with limited influence of cardiovascular risk factors. This allowed the development of a mathematical tool for prediction of individual CAC progression, enabling anticipation of the age when CAC thresholds of high risk are reached.

[1]  D. Grönemeyer,et al.  Effect of smoking and other traditional risk factors on the onset of coronary artery calcification: results of the Heinz Nixdorf recall study. , 2014, Atherosclerosis.

[2]  D. Grönemeyer,et al.  Gender-specific association of coronary artery calcium and lipoprotein parameters: the Heinz Nixdorf Recall Study. , 2013, Atherosclerosis.

[3]  O. Ratib,et al.  Improvement in coronary circulatory function in morbidly obese individuals after gastric bypass-induced weight loss: relation to alterations in endocannabinoids and adipocytokines. , 2013, European heart journal.

[4]  J. Leopold Vascular calcification: an age-old problem of old age. , 2013, Circulation.

[5]  R. Kronmal,et al.  A comparison of outcomes with coronary artery calcium scanning in unselected populations: the Multi-Ethnic Study of Atherosclerosis (MESA) and Heinz Nixdorf RECALL study (HNR). , 2013, Journal of cardiovascular computed tomography.

[6]  Randall C. Thompson,et al.  Atherosclerosis across 4000 years of human history: the Horus study of four ancient populations , 2013, The Lancet.

[7]  M. Budoff,et al.  Impact of coronary artery calcium progression and statin therapy on clinical outcome in subjects with and without diabetes mellitus. , 2013, The American journal of cardiology.

[8]  N. Reinsch,et al.  Comparison of dual-source and electron-beam CT for the assessment of coronary artery calcium scoring. , 2012, The British journal of radiology.

[9]  M. Budoff,et al.  Improvement of cardiovascular risk prediction using coronary imaging: subclinical atherosclerosis: the memory of lifetime risk factor exposure. , 2012, European heart journal.

[10]  P. Greenland,et al.  Prediction of coronary artery calcium progression in individuals with low Framingham Risk Score: the Multi-Ethnic Study of Atherosclerosis. , 2012, JACC. Cardiovascular imaging.

[11]  S. Moebus,et al.  Subclinical Coronary Atherosclerosis Predicts Cardiovascular Risk in Different Stages of Hypertension: Result of the Heinz Nixdorf Recall Study , 2012, Hypertension.

[12]  Randall C. Thompson,et al.  Atherosclerosis in ancient Egyptian mummies: the Horus study. , 2011, JACC. Cardiovascular imaging.

[13]  Daniel S Berman,et al.  Progression of coronary artery calcium predicts all-cause mortality. , 2010, JACC. Cardiovascular imaging.

[14]  Klaus Mann,et al.  Coronary risk stratification, discrimination, and reclassification improvement based on quantification of subclinical coronary atherosclerosis: the Heinz Nixdorf Recall study. , 2010, Journal of the American College of Cardiology.

[15]  Daniel S Berman,et al.  Determinants of coronary calcium conversion among patients with a normal coronary calcium scan: what is the "warranty period" for remaining normal? , 2010, Journal of the American College of Cardiology.

[16]  D. Grönemeyer,et al.  Smoking cessation and subclinical atherosclerosis--results from the Heinz Nixdorf Recall Study. , 2009, Atherosclerosis.

[17]  R. Kronmal,et al.  Signs of subclinical coronary atherosclerosis in relation to risk factor distribution in the Multi-Ethnic Study of Atherosclerosis (MESA) and the Heinz Nixdorf Recall Study (HNR) , 2008, European heart journal.

[18]  S. Moebus,et al.  Association of impaired fasting glucose and coronary artery calcification as a marker of subclinical atherosclerosis in a population-based cohort—results of the Heinz Nixdorf Recall Study , 2008, Diabetologia.

[19]  S. Moebus,et al.  Comparison of subclinical coronary atherosclerosis and risk factors in unselected populations in Germany and US-America. , 2007, Atherosclerosis.

[20]  Xihong Lin,et al.  Coronary Artery Calcification Progression Is Heritable , 2007, Circulation.

[21]  Steven Shea,et al.  Risk Factors for the Progression of Coronary Artery Calcification in Asymptomatic Subjects: Results From the Multi-Ethnic Study of Atherosclerosis (MESA) , 2007, Circulation.

[22]  S. Möhlenkamp,et al.  [Prognostic significance of coronary calcification in asymptomatic persons]. , 2007, MMW, Fortschritte der Medizin.

[23]  Mark A. Hlatky,et al.  ACCF/AHA 2007 Clinical Expert Consensus Document on Coronary Artery Calcium Scoring By Computed Tomography in Global Cardiovascular Risk Assessment and in Evaluation of Patients With Chest Pain , 2007 .

[24]  A. Schmermund,et al.  Non-invasive screening for coronary artery disease: calcium scoring , 2006, Heart.

[25]  W. Howard Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins , 2007 .

[26]  R. Prescott,et al.  Progressive coronary calcification despite intensive lipid-lowering treatment: a randomised controlled trial , 2006, Heart.

[27]  S. Achenbach,et al.  Effect of Intensive Versus Standard Lipid-Lowering Treatment With Atorvastatin on the Progression of Calcified Coronary Atherosclerosis Over 12 Months: A Multicenter, Randomized, Double-Blind Trial , 2006, Circulation.

[28]  Richard A. Kronmal,et al.  Distribution of Coronary Artery Calcium by Race, Gender, and Age: Results from the Multi-Ethnic Study of Atherosclerosis (MESA) , 2005, Circulation.

[29]  R. Collins,et al.  Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins , 2005, The Lancet.

[30]  T. Callister,et al.  Aggressive Versus Moderate Lipid-Lowering Therapy in Hypercholesterolemic Postmenopausal Women: Beyond Endorsed Lipid Lowering With EBT Scanning (BELLES) , 2005, Circulation.

[31]  Y. Arad,et al.  Treatment of asymptomatic adults with elevated coronary calcium scores with atorvastatin, vitamin C, and vitamin E: the St. Francis Heart Study randomized clinical trial. , 2005, Journal of the American College of Cardiology.

[32]  M. Budoff,et al.  Progression of Coronary Artery Calcium and Occurrence of Myocardial Infarction in Patients With and Without Diabetes Mellitus , 2005, Hypertension.

[33]  R. Detrano,et al.  Ethnic Differences in Coronary Calcification: The Multi-Ethnic Study of Atherosclerosis (MESA) , 2005, Circulation.

[34]  S. Moebus,et al.  Baseline recruitment and analyses of nonresponse of the Heinz Nixdorf recall study: Identifiability of phone numbers as the major determinant of response , 2005, European Journal of Epidemiology.

[35]  D. Rosskopf,et al.  Worldwide ethnic distribution of the G protein beta3 subunit 825T allele and its association with obesity in Caucasian, Chinese, and Black African individuals. , 1999, Journal of the American Society of Nephrology : JASN.

[36]  Arya M. Sharma,et al.  Association of a human G-protein β3 subunit variant with hypertension , 1998, Nature Genetics.

[37]  R. Detrano,et al.  Quantification of coronary artery calcium using ultrafast computed tomography. , 1990, Journal of the American College of Cardiology.